Parents in Ohio lost custody of their 17-year-old daughter Friday because a judge ruled that she should be allowed to receive therapy, including testosterone therapy, to identify as a boy.
Without commenting on the specifics of this case just outside Cincinnati, Americans can expect to see more cases like it as government officials side with transgender activists to promote a radical view of the human person and endorse entirely experimental medical procedures. At stake are not only parental rights, but the wellbeing of children who suffer from gender dysphoria.
Here’s what you need to know.
Transgender activists maintain that when a child identifies as the opposite sex in a manner that is “consistent, persistent, and insistent,” the appropriate response is to support that identification. This requires a four-part protocol, as I painstakingly detail in my new book, When Harry Became Sally: Responding to the Transgender Moment:
First, a social transition: giving the child a new wardrobe, a new name, new pronouns, and generally treating the child as if he or she were the opposite sex.
Second, a child approaching puberty will be placed on puberty blockers to prevent the normal process of maturation and development. This means there will be no progression of the pubertal stage, and a regression of sex characteristics that have already developed. Puberty-blocking drugs are not FDA approved for gender dysphoria, but physicians use them off-label for this purpose.
Third, around age 16, comes the administration of cross-sex hormones: Boys will be given feminizing hormones such as estrogen, and girls will be given masculinizing hormones such as androgens (testosterone). The purpose is to mimic the process of puberty that would occur in the opposite sex.
Read more at The Stream.